84-3085-22 [取扱停止]MEF2C, phosphorylated (Thr20) (Myocyte-specific Enhancer Factor 2C) (MaxLight 650) 100ul M9769-97-ML650
特徴
MaxLight™650 is a new Far-IR stable dye conjugate comparable to Alexa Fluor™647, DyLight™649, Cy5™ and offers better labeling efficiency, brighter imaging and increased immunodetection.
Absorbance (655nm); Emission (676nm); Extinction Coefficient 250,000.
MEF2C is a transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes.
This protein controls cardiac morphogenesis and myogenesis, and is also involved in vascular development.
It may also be involved in neurogenesis and in the development of cortical architecture.
Applications:Suitable for use in FLISA and Dot Blot.
Other applications not tested.
Recommended Dilution:FLISA: 1:1,000 Dot Blot: 1:100-1:500Optimal dilutions to be determined by the researcher.
Storage and Stability:Store product at 4°C in the dark.
DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
Dilute required amount only prior to immediate use.
Further dilutions can be made in assay buffer.
Caution: MaxLight™650 conjugates are sensitive to light.
For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Note: Applications are based on unconjugated antibody.
仕様
Size:100ul
Host:rabbit
Source Antibody:human
Grade:Affinity Purified
Purity:Purified by immunoaffinity chromatography.
Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™650.
Specificity:Recognizes human MEF2C when phosphorylated at Thr20.
Isotype:IgG
Calc Applications Abbrev:DB FLISA WB
Calc Crossreactivity:Hu
Immunogen:Synthetic phosphopeptide corresponding to amino acid residues surrounding Thr20 of human MEF2C (KLH).
Shelf Life:1year
Swiss Prot Number:Q06413
EU Commodity Code:30021010
この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
【試薬に関するお問合せ】
アズワン株式会社 試薬・プロセス材料グループ
TEL:06-6447-8641
FAX:06-6447-8642
E-mail:[email protected]